Race Oncology goes it alone with retail raise – The Australian Financial Review

Cancer biotech Race Oncology is tapping its base of loyal retail shareholders for a fresh capital raise of up to $30 million,
The early stage biotech company, which has not enlisted the help of any bankers to run the raising, has set a wide target range…

Click here to view the original article.